Serial analysis of gene expression in mouse kidney following angiotensin II administration

Physiological Genomics

Volumn 16, Issue , 2004, Pages 90-98

  Schwartz, Faina ^a   Duka, Arvi ^a   Triantafyllidi, Elena ^a   Johns, Conrado ^a   Duka, Irena ^a   Cui, Jing ^a   Gavras, Haralambos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin excess; Cathepsin D; Hypertension; Mouse kidney transcriptome; Tissue kallikrein

Indexed keywords

ANGIOTENSIN; CATHEPSIN D; DNA; KALLIKREIN; RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; HYPERTENSION; KIDNEY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLETHYSMOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; UPREGULATION;

ANGIOTENSIN II; ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LIBRARY; GENOME; GENOMICS; HYPERTENSION; KIDNEY; MALE; MICE; MICE, INBRED STRAINS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; SALVIA;

EID: 1842430823     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00108.2003     Document Type: Article

References (74)

1. Ader JL, Pollock DM, Butterfield MI, and Arendshorst WJ. Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 248: F396-F403, 1985.
2. Altschul SF, Gish W, Miller W, Myers EW, and Lipman DJ. Basic local alignment search tool. J Mol Biol 215: 403-410, 1990.
3. Audic S and Claverie JM. The significance of digital gene expression profiles. Genome Res 7: 986-995, 1997.
4. Bernstein HG, Bruszis S, Schmidt D, Wiederanders B, and Dorn A. Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type. J Hirnforsch 30: 613-618, 1989.
5. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, and Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284: F955-F965, 2003. First published January 14, 2003; 10.1152/ajprenal.00246.2002.
6. Braam B, Allen P, Benes E, Koomans HA, Navar LG, and Hammond T. Human proximal tubular cell responses to angiotensin II analyzed using DNA microarray. Eur J Pharmacol 464: 87-94, 2003.
7. Campos AH, Zhao Y, Pollman MJ, and Gibbons GH. DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: potential mediators of vascular disease. Circ Res 92: 111-118, 2003.
8. Cavailles V, Augereau P, and Rochefort H. Cathepsin D gene of human MCF7 cells contains estrogen-responsive sequences in its 5′ proximal flanking region. Biochem Biophys Res Commun 174: 816-824, 1991.
9. Chao C, Madeddu P, Wang C, Liang Y, Chao L, and Chao J. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 271: F78-F86, 1996.
10. Chen H, Centola M, Altschul SF, and Metzger H. Characterization of gene expression in resting and activated mast cells. J Exp Med 188: 1657-1668, 1998.
11. Cody RJ. The integrated effects of angiotensin II. Am J Cardiol 79: 9-11, 1997.
12. Comelli M, Di Pancrazio F, and Mavelli I. Apoptosis is induced by decline of mitochondrial ATP synthesis in erythroleukemia cells. Free Radic Biol Med 34: 1190-1199, 2003.
13. Corvol P, Persu A, Gimenez-Roqueplo AP, and Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension 33: 1324-1331, 1999.
14. De Stefanis D, Reffo P, Bonelli G, Baccino FM, Sala G, Ghidoni R, Codogno P, and Isidoro C. Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells. Biol Chem 383: 989-999, 2002.
15. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, and Singhal PC. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 283: F173-F180, 2002. First published January 8, 2002; 10.1152/ajprenal.00240.2001.
16. El-Meanawy MA, Schelling JR, Pozuelo F, Churpek MM, Ficker EK, Iyengar S, and Sedor JR. Use of serial analysis of gene expression to generate kidney expression libraries. Am J Physiol Renal Physiol 279: F383-F392, 2000.
17. Gavras H and Brunner HR. Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure. Hypertension 37: 342-345, 2001.
18. Gavras H, Lever AF, Brown JJ, Macadam RF, and Robertson JI. Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet 2: 19-22, 1971.
19. Gavras I and Gavras H. Angiotensin II as a cardiovascular risk factor. J Hum Hypertens 16, Suppl 2: S2-S6, 2002.
20. Geromel V, Kadhom N, Cebalos-Picot I, Ouari O, Polidori A, Munnich A, Rotig A, and Rustin P. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet 10: 1221-1228, 2001.
21. Glondu M, Liaudet-Coopman E, Derocq D, Platet N, Rochefort H, and Garcia M. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene 21: 5127-5134, 2002.
22. Guan S, Fox J, Mitchell KD, and Navar LG. Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension 20: 763-767, 1992.
23. Johns C, Gavras I, Handy DE, Salomao A, and Gavras H. Models of experimental hypertension in mice. Hypertension 28: 1064-1069, 1996.
24. Kagedal K, Johansson U, and Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15: 1592-1594, 2001.
25. Kenzelmann M and Muhlemann K. Substantially enhanced cloning efficiency of SAGE (Serial Analysis of Gene Expression) by adding a heating step to the original protocol. Nucleic Acids Res 27: 917-918, 1999.
26. Kobori H, Harrison-Bernard LM, and Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 37: 1329-1335, 2001.
27. Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE, Marra MA, Prange C, Morin PJ, Polyak K, Papadopoulos N, Vogelstein B, Kinzler KW, Strausberg RL, and Riggins GJ. A public database for gene expression in human cancers. Cancer Res 59: 5403-5407, 1999.
28. Lalouel JM. Large-scale search for genes predisposing to essential hypertension. Am J Hypertens 16: 163-166, 2003.
29. Liang X, Zhang H, Zhou A, Hou P, and Wang H. Screening and identification of the up-regulated genes in human mesangial cells exposed to angiotensin II. Hypertens Res 26: 225-235, 2003.
30. Livshits G, Ginsburg E, and Kobyliansky E. Heterogeneity of genetic control of blood pressure in ethnically different populations. Hum Biol 71: 685-708, 1999.
31. Lodha S, Dani D, Mehta R, Bhaskaran M, Reddy K, Ding G, and Singhal PC. Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med 8: 830-840, 2002.
32. Madden SL, Galella EA, Zhu J, Bertelsen AH, and Beaudry GA. SAGE transcript profiles for p53-dependent growth regulation. Oncogene 15: 1079-1085, 1997.
33. Man MZ, Wang X, and Wang Y. POWER_SAGE: comparing statistical tests for SAGE experiments. Bioinformatics 16: 953-959, 2000.
34. Margolius HS, Geller R, De Jong W, Pisano JJ, and Sjoerdsma A. Altered urinary kallikrein excretion in rats with hypertension. Circ Res 30: 358-362, 1972.
35. Margulies EH and Innis JW. eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE). Bioinformatics 16: 650-651, 2000.
36. Margulies EH, Kardia SL, and Innis JW. Identification and prevention of a GC content bias in SAGE libraries. Nucleic Acids Res 29: e60, 2001.
37. Miller RA, Galecki A, and Shmookler-Reis RJ. Interpretation, design, and analysis of gene array expression experiments. J Gerontol A Biol Sci Med Sci 56: B52-B57, 2001.
38. Morris BJ. Activation of human inactive ("pro-") renin by cathepsin D and pepsin. J Clin Endocrinol Metab 46: 153-157, 1978.
39. Navar LG and Nishiyama A. Intrarenal formation of angiotensin II. Contrib Nephrol 135: 1-15, 2001.
40. Nicholls MG and Robertson JI. The renin-angiotensin system in the year 2000. J Hum Hypertens 14: 649-666, 2000.
41. Okazaki Y et al. (FANTOM Consortium; RIKEN Genome Exploration Research Group Phase I and II Team). Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420: 563-573, 2002.
42. Ollinger K. Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. Arch Biochem Biophys 373: 346-351, 2000.
43. Powell J. Enhanced concatemer cloning-a modification to the SAGE (Serial Analysis of Gene Expression) technique. Nucleic Acids Res 26: 3445-3446, 1998.
44. Pravenec M, Kren V, Kunes J, Scicli AG, Carretero OA, Simonet L, and Kurtz TW. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 17: 242-246, 1991.
45. Reckelhoff JF and Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003; 10.1152/ajpregu.00491.2002.
46. Roberg K, Kagedal K, and Ollinger K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 161: 89-96, 2002.
47. Roberg K and Ollinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 152: 1151-1156, 1998.
48. Ruijter JM, Van Kampen AH, and Baas F. Statistical evaluation of SAGE libraries: consequences for experimental design. Physiol Genomics 11: 37-44, 2002; 10.1152/physiolgenomics.00042.2002.
49. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, and von Figura K. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 14: 3599-3608, 1995.
50. Schelling JR, El-Meanawy MA, Barathan S, Dodig T, Iyengar SK, and Sedor JR. Generation of kidney transcriptomes using serial analysis of gene expression. Exp Nephrol 10: 82-92, 2002.
51. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, and Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol Endocrinol Metab 263: E863-E869, 1992.
52. Sigmund CD, Jones CA, Fabian JR, Mullins JJ, and Gross KW. Tissue and cell specific expression of a renin promoter-reporter gene construct in transgenic mice. Biochem Biophys Res Commun 170: 344-350, 1990.
53. Soulet D and Rivest S. Perspective: how to make microarray, serial analysis of gene expression, and proteomic relevant to day-to-day endocrine problems and physiological systems. Endocrinology 143: 1995-2001, 2002.
54. Stollberg J, Urschitz J, Urban Z, and Boyd CD. A quantitative evaluation of SAGE. Genome Res 10: 1241-1248, 2000.
55. Sugiyama F, Churchill GA, Li R, Libby LJM, Carver T, Yagami KI, John SWM, and Paigen B. QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice. Physiol Genomics 10: 5-12, 2002. First published April 30, 2002; 10.1152/physiolgenomics.00002.2002.
56. Suzuki S, Franco-Saenz R, Tan SY, and Mulrow PJ. Direct action of kallikrein and other proteases on the renin-angiotensin system. Hypertension 3: 113-117, 1981.
57. Suzuki S, Franco-Saenz R, Tan SY, and Mulrow PJ. Direct action of rat urinary kallikrein on rat kidney to release renin. J Clin Invest 66: 757-762, 1980.
58. Taanman JW. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410: 103-123, 1999.
59. Taugner R, Yokota S, Buhrle CP, and Hackenthal E. Cathepsin D coexists with renin in the secretory granules of juxtaglomerular epithelioid cells. Histochemistry 84: 19-22, 1986.
60. van Kampen AH, van Schaik BD, Pauws E, Michiels EM, Ruijter JM, Caron HN, Versteeg R, Heisterkamp SH, Leunissen JA, Baas F, and van der Mee M. USAGE: a web-based approach towards the analysis of SAGE data. Serial Analysis of Gene Expression. Bioinformatics 16: 899-905, 2000.
61. Vaughan DE. Angiotensin, fibrinolysis, and vascular homeostasis. Am J Cardiol 87: 18C-24C, 2001.
62. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L, Zhang W, Zhang X, Zhou W, Haluska FG, Jen J, Sukumar S, Landes GM, Riggins GJ, Vogelstein B, and Kinzler KW. Analysis of human transcriptomes. Nat Genet 23: 387-388, 1999.
63. Velculescu VE, Zhang L, Vogelstein B, and Kinzler KW. Serial analysis of gene expression. Science 270: 484-487, 1995.
64. Virlon B, Cheval L, Buhler JM, Billon E, Doucet A, and Elalouf JM. Serial microanalysis of renal transcriptomes. Proc Natl Acad Sci USA 96: 15286-15291, 1999.
65. Von Thun AM, Vari RC, el-Dahr SS, and Navar LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol Renal Fluid Electrolyte Physiol 266: F120-F128, 1994.
66. Wang C, Chao C, Chen LM, Chao L, and Chao J. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats. Am J Physiol Renal Fluid Electrolyte Physiol 271: F824-F830, 1996.
67. Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, and Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 23: 236-243, 1994.
68. Waterston RH et al. (Mouse Genome Sequencing Consortium). Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562, 2002.
69. Wolf G. Free radical production and angiotensin. Curr Hypertens Rep 2: 167-173, 2000.
70. Woodley-Miller C, Chao J, and Chao L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J Hypertens 7: 865-871, 1989.
71. Wu GS, Saftig P, Peters C, and El-Deiry WS. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16: 2177-2183, 1998.
72. Yu H, Song Q, Freedman BI, Chao J, Chao L, Rich SS, and Bowden DW. Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney Int 61: 1030-1039, 2002.
73. Yuan B, Liang M, Yang Z, Rute E, Taylor N, Olivier M, and Cowley AW Jr. Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG II. Am J Physiol Regul Integr Comp Physiol 284: R1219-R1230, 2003. First published January 23, 2003; 10.1152/ajpregu.00257.2002.
74. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, and Kinzler KW. Gene expression profiles in normal and cancer cells. Science 276: 1268-1272, 1997.